IN2014DE00737A - - Google Patents
Info
- Publication number
- IN2014DE00737A IN2014DE00737A IN737DE2014A IN2014DE00737A IN 2014DE00737 A IN2014DE00737 A IN 2014DE00737A IN 737DE2014 A IN737DE2014 A IN 737DE2014A IN 2014DE00737 A IN2014DE00737 A IN 2014DE00737A
- Authority
- IN
- India
- Prior art keywords
- solvent
- branched
- alcohol
- linear
- water content
- Prior art date
Links
- 239000002904 solvent Substances 0.000 abstract 4
- MWWSFMDVAYGXBV-FGBSZODSSA-N (7s,9s)-7-[(2r,4s,5r,6s)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7h-tetracene-5,12-dione;hydron;chloride Chemical compound Cl.O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(=O)CO)[C@H]1C[C@H](N)[C@@H](O)[C@H](C)O1 MWWSFMDVAYGXBV-FGBSZODSSA-N 0.000 abstract 2
- 229960003265 epirubicin hydrochloride Drugs 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract 1
- AMQJEAYHLZJPGS-UHFFFAOYSA-N N-Pentanol Chemical compound CCCCCO AMQJEAYHLZJPGS-UHFFFAOYSA-N 0.000 abstract 1
- 238000002425 crystallisation Methods 0.000 abstract 1
- 230000008025 crystallization Effects 0.000 abstract 1
- 238000010438 heat treatment Methods 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 150000004682 monohydrates Chemical class 0.000 abstract 1
- 239000013557 residual solvent Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/01—Hydrocarbons
- A61K31/015—Hydrocarbons carbocyclic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
- A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H1/00—Processes for the preparation of sugar derivatives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/20—Carbocyclic rings
- C07H15/24—Condensed ring systems having three or more rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/20—Carbocyclic rings
- C07H15/24—Condensed ring systems having three or more rings
- C07H15/252—Naphthacene radicals, e.g. daunomycins, adriamycins
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361787097P | 2013-03-15 | 2013-03-15 | |
| EP13159392.3A EP2778171A1 (en) | 2013-03-15 | 2013-03-15 | Crystalline monohydrate of epirubicin hydrochloride |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2014DE00737A true IN2014DE00737A (cs) | 2015-06-19 |
Family
ID=48013735
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN737DE2014 IN2014DE00737A (cs) | 2013-03-15 | 2014-03-13 |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US20140271874A1 (cs) |
| EP (2) | EP2778171A1 (cs) |
| JP (1) | JP5964339B2 (cs) |
| KR (1) | KR101751099B1 (cs) |
| CN (1) | CN104045672B (cs) |
| DK (1) | DK2778172T3 (cs) |
| ES (1) | ES2623218T3 (cs) |
| HU (1) | HUE034152T2 (cs) |
| IN (1) | IN2014DE00737A (cs) |
| PL (1) | PL2778172T3 (cs) |
| PT (1) | PT2778172T (cs) |
| RS (1) | RS55850B1 (cs) |
| RU (2) | RU2630692C2 (cs) |
| SI (1) | SI2778172T1 (cs) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2805723T3 (es) * | 2015-03-30 | 2021-02-15 | Meiji Seika Pharma Co Ltd | Método para producir epirrubicina e intermedio de producción novedoso para la misma |
| CN104861014B (zh) * | 2015-06-03 | 2017-09-29 | 道中道（菏泽）制药有限公司 | 一种盐酸表阿霉素结晶的制备方法 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1155446B (it) | 1982-12-23 | 1987-01-28 | Erba Farmitalia | Procedimento per la purificazione di glucosidi antraciclinonici mediante adsobimento selettivo su resine |
| BRPI0408568A (pt) * | 2003-03-21 | 2006-03-21 | Dsm Ip Assets Bv | triidrato de amoxicilina |
| CN100412084C (zh) * | 2003-07-02 | 2008-08-20 | 獀洛克斯股份有限公司 | 热稳定的结晶盐酸表柔比星及其制造方法 |
| US20090099346A1 (en) * | 2003-07-02 | 2009-04-16 | Victor Matvienko | Thermally stable crystalline epirubicin hydrochloride |
| GB0902009D0 (en) * | 2009-02-09 | 2009-03-11 | Innospec Ltd | Improvements in fuels |
| ES2351494B1 (es) * | 2009-06-30 | 2011-11-28 | Consejo Superior De Investigaciones Cientificas (Csic) (85,7%) | Material organo-inorganico microporoso cristalino basado en cationes alcalinoterreos, procedimiento de preparacion y usos |
| KR101125460B1 (ko) * | 2010-03-24 | 2012-03-28 | 동아제약주식회사 | 에피루비신 염산염의 신규한 결정형 |
| CN102120750B (zh) * | 2011-01-30 | 2013-04-03 | 山东新时代药业有限公司 | 一种盐酸表柔比星的纯化方法 |
| DE102011103751A1 (de) * | 2011-05-31 | 2012-12-06 | Heraeus Precious Metals Gmbh & Co. Kg | Kristallisierung von Epirubicinhydrochlorid |
-
2013
- 2013-03-15 EP EP13159392.3A patent/EP2778171A1/en not_active Withdrawn
-
2014
- 2014-03-13 JP JP2014049587A patent/JP5964339B2/ja active Active
- 2014-03-13 HU HUE14159462A patent/HUE034152T2/en unknown
- 2014-03-13 SI SI201430193A patent/SI2778172T1/sl unknown
- 2014-03-13 PL PL14159462T patent/PL2778172T3/pl unknown
- 2014-03-13 US US14/208,133 patent/US20140271874A1/en not_active Abandoned
- 2014-03-13 RS RS20170359A patent/RS55850B1/sr unknown
- 2014-03-13 CN CN201410092353.9A patent/CN104045672B/zh active Active
- 2014-03-13 DK DK14159462.2T patent/DK2778172T3/en active
- 2014-03-13 RU RU2014109682A patent/RU2630692C2/ru active
- 2014-03-13 KR KR1020140029344A patent/KR101751099B1/ko active Active
- 2014-03-13 ES ES14159462.2T patent/ES2623218T3/es active Active
- 2014-03-13 IN IN737DE2014 patent/IN2014DE00737A/en unknown
- 2014-03-13 EP EP14159462.2A patent/EP2778172B1/en active Active
- 2014-03-13 PT PT141594622T patent/PT2778172T/pt unknown
-
2017
- 2017-05-23 RU RU2017117890A patent/RU2700683C2/ru active
-
2019
- 2019-07-24 US US16/520,767 patent/US20190382432A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| JP2014181235A (ja) | 2014-09-29 |
| RU2017117890A (ru) | 2018-11-26 |
| CN104045672B (zh) | 2017-09-15 |
| US20140271874A1 (en) | 2014-09-18 |
| SI2778172T1 (sl) | 2017-07-31 |
| RU2630692C2 (ru) | 2017-09-12 |
| HK1199264A1 (en) | 2015-06-26 |
| RS55850B1 (sr) | 2017-08-31 |
| PT2778172T (pt) | 2017-05-03 |
| RU2700683C2 (ru) | 2019-09-19 |
| EP2778171A1 (en) | 2014-09-17 |
| CN104045672A (zh) | 2014-09-17 |
| KR101751099B1 (ko) | 2017-06-26 |
| RU2014109682A (ru) | 2015-09-20 |
| HUE034152T2 (en) | 2018-01-29 |
| RU2017117890A3 (cs) | 2018-11-26 |
| PL2778172T3 (pl) | 2017-08-31 |
| DK2778172T3 (en) | 2017-04-10 |
| EP2778172A1 (en) | 2014-09-17 |
| EP2778172B1 (en) | 2017-02-01 |
| ES2623218T3 (es) | 2017-07-10 |
| KR20140113441A (ko) | 2014-09-24 |
| US20190382432A1 (en) | 2019-12-19 |
| JP5964339B2 (ja) | 2016-08-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH12019000462A1 (en) | A novel crystalline form of a benzimidazole derivative and a preparation method thereof | |
| HK1255390A1 (zh) | 用於生產大麻二酚和△-9-四氫大麻酚的方法 | |
| NZ705213A (en) | C17-heteroaryl derivatives of oleanolic acid and methods of use thereof | |
| PH12015500491A1 (en) | C17-alkanediyl and alkenediyl derivatives of oleanolic acid and methods of use thereof | |
| WO2014141129A3 (en) | Novel methods, compounds, and compositions for inhibition of ros | |
| MX375872B (es) | Procedimiento de preparacion de 5-fluoro-1h-pirazolopiridinas sustituidas. | |
| MX395263B (es) | Forma cristalina de base libre de lorlatinib | |
| CU24263B1 (es) | Derivados de imidazopiridazinas inhibidores de quinasa akt, útiles para el tratamiento del cáncer | |
| AU2014230812A8 (en) | Process for making benzoxazepin compounds | |
| BR112018006519A2 (pt) | compostos de fórmula, processo para a síntese de compostos, compostos intermediários x, composição, utilização de um composto de fórmula, método para o combate de fungos e semente | |
| EA200801893A1 (ru) | Производные тетрагидронафталина, способ их получения и их применение в качестве ингибиторов воспаления | |
| PT2462098E (pt) | Processos para a preparação de derivados de ácido 1-(2- halobifenil-4-il)-ciclopropanocarboxílico | |
| MX2016000968A (es) | Composiciones edulcorantes estables. | |
| MX2016004963A (es) | Sal y formas cristalinas de inhibidores de quinasa tipo polo-4. | |
| EA201391214A1 (ru) | Композиции, содержащие алкилалкоксисульфонаты, для производства термостабильных пен | |
| WO2013190455A3 (en) | Process for the preparation of lurasidone hydrochloride | |
| MY164880A (en) | Process for the preparation of isoxazolyl-methoxy-nicotinic acids | |
| EP4174072A3 (en) | Process for the preparation of morphinan-6-one compounds | |
| MY192148A (en) | Steviol glycoside composition | |
| BR112017011275A2 (pt) | composição, e, processo para a produção de xarope de glicose. | |
| BR112015031820A2 (pt) | composto, composição farmacêutica, intermediário, processo para a preparação de um composto e métodos | |
| IN2014DE00737A (cs) | ||
| MX2020009462A (es) | Procesos para la preparación de compuestos de pirimidinilciclopentano. | |
| IN2013DE02503A (cs) | ||
| GB2523674A (en) | Compounds as inhibitor of DNA double-strand break repair, methods and applications thereof |